PacBio Adds David Botstein to its Board of Directors

Botstein Joins PacBioPacific Biosciences PacBio announced today that reputed genome scientist/geneticist Prof.David Botstein, Ph.D. has joined PacBio’s board of directors. David Botstein is currently the Director of the Lewis-Sigler Institute for Integrative Genomics and Anthony B. Evnin Professor of Genomics at Princeton University to its Board of Directors.

Dr. Botstein has significant made significant contributions to human genetics. He published a landmark paper in 1980 with Dr. Eric Lander that helped human genome sequencing. He is also well-known for his contribution in yeast genetics and undergraduate teaching. Even now he is actively involved in teaching and moved to Princeton in early 2000 to begin integrative sciences program for undergraduates. Dr. Botstein also served at Genentech as Vice President for Science and he is currently on the Scientific Resource Board. Michael Hunkapiller, Chairman and Chief Executive Officer of Pacific Biosciences said

David and I have a long history of collaboration based on our mutual interest in driving critical technologies that can open new avenues of scientific exploration. I am honored that he has accepted this position and is interested in being closely involved in ensuring the success of our Single Molecule, Real-Time technology in the research markets.

In the PacBio’s press release announcing the news Dr. Botstein said

We are moving toward an exciting era where the cost of producing sequencing information is going down, and now the emergence of the high-quality, multi-kilobase sequence will be a double game changer. Even with today’s advanced sequencers, a lot of good biology is being left on the table because we cannot fully assemble genomes for the many organisms for which there is no reference, or because we are missing difficult to sequence regions of critical variation. Pacific Biosciences’ long-read technology offers the field something that currently does not otherwise exist — the ability to create high quality de novo assemblies, improve re-assemblies for complex organisms, and understand DNA modifications within sequences.

 

Speak Your Mind

*